Cannabis Strategic Ventures (OTC: NUGS) this morning
announced a major common share restructuring led by its CEO Simon Yu, who will
cancel 60 million shares with the intention to increase shareholder value as
well as uplist to the OTCQB Venture Market Place. This latest restructuring
expands on an August 2018 undertaking where NUGS canceled 75.6 million shares,
including 20 million from Yu, also aimed at increasing value for investors and to
qualify the company for OTCQB uplisting. “2018 has been a tremendous year for
the cannabis industry, marijuana stocks and cannabis investors. Reducing the
number of outstanding shares increases the value for our shareholders and
signals management’s commitment to building an industry-leading organization,”
Cannabis Strategic Ventures CEO Simon Yu stated in the news release. “Along
with increasing shareholder value, moving to a higher tier exchange is a
priority for our Company. OTCQB, will help broaden our shareholder base,
provide better access to institutional investors and create additional value to
current shareholders.”
To view the full press release, visit http://ibn.fm/bTIz2
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures is a Los Angeles based firm that
incubates, develops and partners with category leaders within the cannabis
sector. The Firm’s NUGS brand experience provides mentorship and a range of
essential services to emerging and existing Cannabis consumer brands. The
company recently completed a name and symbol change from Cascade Energy, Inc.
Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter
Market with the stock symbol NUGS. For more information, visit the company’s
website at www.CannabisStrategic.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
